Authors:
HOEPELMAN IM
MOLLERS MJ
VANSCHIE MH
GREEFHORST APM
SCHLOSSER NJJ
DAMSTE EJS
VANDEMOOSDIJK CNF
DALINGHAUS WH
ELAND ME
MOL SJM
ROZENBERGARSKA M
Citation: Im. Hoepelman et al., A SHORT (3-DAY) COURSE OF AZITHROMYCIN TABLETS VERSUS A 10-DAY COURSEOF AMOXICILLIN-CLAVULANIC ACID (CO-AMOXICLAV) IN THE TREATMENT OF ADULTS WITH LOWER RESPIRATORY-TRACT INFECTIONS AND EFFECTS ON LONG-TERM OUTCOME, International journal of antimicrobial agents, 9(3), 1998, pp. 141-146
Authors:
JASPERS CAJJ
KIEFT H
SPEELBERG B
BUITING A
KOOIJ MV
RUYS GJHM
VINCENT HH
VERMEULEN MCA
OLINK AG
HOEPELMAN IM
Citation: Cajj. Jaspers et al., MEROPENEM VERSUS CEFUROXIME PLUS GENTAMICIN FOR TREATMENT OF SERIOUS INFECTIONS IN ELDERLY PATIENTS, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1233-1238
Authors:
HUSTINX WNM
VANKESSEL CPM
HEEZIUS E
BURGERS S
LAMMERS JW
HOEPELMAN IM
Citation: Wnm. Hustinx et al., EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TREATMENT ONGRANULOCYTE FUNCTION AND RECEPTOR EXPRESSION IN PATIENTS WITH VENTILATOR-DEPENDENT PNEUMONIA, Clinical and experimental immunology, 112(2), 1998, pp. 334-340
Authors:
CHAKA W
VERHEUL AFM
VAISHNAV VV
CHERNIAK R
SCHARRINGA J
VERHOEF J
SNIPPE H
HOEPELMAN IM
Citation: W. Chaka et al., CRYPTOCOCCUS-NEOFORMANS AND CRYPTOCOCCAL GLUCURONOXYLOMANNAN, GALACTOXYLOMANNAN, AND MANNOPROTEIN INDUCE DIFFERENT LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Infection and immunity, 65(1), 1997, pp. 272-278
Authors:
SCHNEIDER MME
FLUIT AC
BORLEFFS JCC
VANDERWAL G
BERGARSKA MR
HOEPELMAN IM
Citation: Mme. Schneider et al., EVALUATION OF PCR ASSAY FOR EARLY DIAGNOSIS OF MYCOBACTERIUM-AVIUM INFECTION, Clinical infectious diseases, 23(4), 1996, pp. 298-298
Authors:
SCHNEIDER MME
SPRENGER MJW
HOEPELMAN IM
VANDERGRAAF Y
BORLEFFS JCC
Citation: Mme. Schneider et al., ANTIBODY-RESPONSE TO TETRAVALENT INFLUENZA SUBUNIT VACCINE IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, International journal of antimicrobial agents, 6(4), 1996, pp. 195-200
Citation: Im. Hoepelman, SPECIAL ISSUE - EPIDEMIOLOGY AND MANAGEMENT OF SYSTEMIC FUNGAL INFECTION - INTRODUCTION, International journal of antimicrobial agents, 6(3), 1996, pp. 129-130
Citation: Im. Hoepelman et B. Dupont, ORAL CANDIDIASIS - THE CLINICAL CHALLENGE OF RESISTANCE AND MANAGEMENT, International journal of antimicrobial agents, 6(3), 1996, pp. 155-159
Authors:
CHAKA W
SCHARRINGA J
VERHEUL AFM
VERHOEF J
VANSTRIJP AG
HOEPELMAN IM
Citation: W. Chaka et al., QUANTITATIVE-ANALYSIS OF PHAGOCYTOSIS AND KILLING OF CRYPTOCOCCUS-NEOFORMANS BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY FLOW-CYTOMETRY, Clinical and diagnostic laboratory immunology, 2(6), 1995, pp. 753-759
Authors:
DEGIER R
KARPERIEN A
BOUTER K
ZWINKELS M
VERHOEF J
KNOL W
BOON T
HOEPELMAN IM
Citation: R. Degier et al., A SEQUENTIAL STUDY OF INTRAVENOUS AND ORAL FLEROXACIN FOR 7 OR 14 DAYS IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS, International journal of antimicrobial agents, 6(1), 1995, pp. 27-30
Citation: Im. Hoepelman et Mme. Schneider, AZITHROMYCIN - THE FIRST OF THE TISSUE-SELECTIVE AZALIDES, International journal of antimicrobial agents, 5(3), 1995, pp. 145-167
Authors:
GEROULANOS SJ
DEPUYDT P
VANKERSHAVER B
PENNINCKX FMA
VEREECKEN LF
DEWAELE B
CHALFINE A
DAZZA F
GOUIN F
SARLES JC
KUJATH P
BASOLI A
SPERANZA V
BELLANTONE R
CRUCITTI F
PACELLI F
HOEPELMAN IM
EGGIMANN P
Citation: Sj. Geroulanos et al., MEROPENEM VERSUS IMIPENEM-CILASTATIN IN INTRAABDOMINAL INFECTIONS REQUIRING SURGERY, Journal of antimicrobial chemotherapy, 36, 1995, pp. 191-205
Citation: Im. Hoepelman, URINARY-TRACT INFECTIONS IN PATIENTS WITH DIABETES-MELLITUS, International journal of antimicrobial agents, 4(2), 1994, pp. 113-116
Authors:
HOEPELMAN IM
HAVINGA WH
BENNE RA
ZWINKELS M
DEWIT MAM
DEHOND HAPM
BOON TA
VISSER MR
VANASBECK FWA
VERHOEF J
Citation: Im. Hoepelman et al., SAFETY AND EFFICACY OF LOMEFLOXACIN VERSUS NORFLOXACIN IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS, European journal of clinical microbiology & infectious diseases, 12(5), 1993, pp. 343-347